22NW, LP
Overview
22NW, LP is a Seattle-based investment firm specializing in long-term, value-oriented investments in small and micro-cap companies. The firm focuses on identifying undervalued securities within the U.S. small-cap market, aiming to capitalize on structural mispricings and performance disparities. Their investment strategy is designed to capture these opportunities over multi-year horizons, emphasizing a disciplined and patient approach to value investing. The firm's portfolio spans various sectors, including technology, healthcare, consumer goods, industrials, materials, and consumer services. 22NW, LP engages in investments across multiple stages, such as early stage, growth, late stage, pre-IPO, buyout, turnaround, and distressed situations. This diversified approach allows the firm to adapt to different market conditions and company needs, providing tailored investment solutions. 22NW, LP has demonstrated its commitment to active engagement with portfolio companies to enhance shareholder value. Notably, in April 2023, the firm reached an agreement with L.B. Foster Company, leading to the appointment of Alexander B. Jones as a non-voting Board Observer. Similarly, in July 2024, 22NW, LP entered into a cooperation agreement with Lifecore Biomedical, Inc., resulting in the addition of four nominees to the company's Board of Directors. These actions reflect the firm's proactive stance in corporate governance and its dedication to fostering value creation within its investments.
Investment Focus
- Minimum initial investment of $5,000,000 for qualified clients.
Portfolio Companies
Reach 22NW, LP directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 22NW, LP
What sectors does 22NW, LP invest in?
22NW, LP invests in Technology, Healthcare, Consumer Goods, Industrials, Materials and Consumer Services, and is based in Seattle, United States. 22NW, LP is listed as a private investment firm in the ConnectSafely investor database.
What stage does 22NW, LP invest at?
22NW, LP backs companies at Early Stage, Growth, Late Stage, Pre-IPO, Buyout and Turnaround.
Which regions does 22NW, LP invest in?
22NW, LP invests across United States.
Who are the partners at 22NW, LP?
Team members listed for 22NW, LP include James Stoner (CFO) and Bryson Hirai-Hadley (Director of Research).
What companies has 22NW, LP invested in?
22NW, LP's portfolio includes L.B. Foster Company, Lifecore Biomedical, Inc., Culp, Inc. and DIRTT Environmental Solutions Ltd..
How do I contact 22NW, LP?
22NW, LP's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database